These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37165825)

  • 1. [Application progress of high-throughput sequencing in antiphospholipid syndrome].
    Liu Q; Yang S; Cui LY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 May; 57(5):766-770. PubMed ID: 37165825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome.
    Liu Q; Yang S; Tan Y; Cui L
    Front Immunol; 2023; 14():1128245. PubMed ID: 37275905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
    Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
    Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The scoring system for the risk-stratification in patients with the antiphospholipid syndrome].
    Oku K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):435-441. PubMed ID: 29367527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Antiphospholipid Antibodies a Surrogate Risk Factor for Thrombosis in Sepsis?
    Thachil J; Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2024 Mar; 50(2):284-287. PubMed ID: 37506732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
    Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z
    Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome.
    Noureldine MHA; Nour-Eldine W; Khamashta MA; Uthman I
    Semin Arthritis Rheum; 2019 Apr; 48(5):860-866. PubMed ID: 30217394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
    Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
    J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome.
    Truglia S; Capozzi A; Mancuso S; Manganelli V; Rapino L; Riitano G; Recalchi S; Colafrancesco S; Ceccarelli F; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Sorice M
    Front Immunol; 2022; 13():932181. PubMed ID: 35860235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
    Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Trespidi L
    Thromb Haemost; 2014 Oct; 112(4):727-35. PubMed ID: 25008944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review.
    Cheng C; Cheng GY; Denas G; Pengo V
    Blood Rev; 2021 Jul; 48():100788. PubMed ID: 33341301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
    da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G
    Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid scoring: significance in diagnosis and prognosis.
    Oku K; Amengual O; Atsumi T
    Lupus; 2014 Oct; 23(12):1269-72. PubMed ID: 25228723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of antiphospholipid antibodies tests].
    Otomo K; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):63-70. PubMed ID: 23629425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.